List of Excipients in API amlodipine besylate and atorvastatin calcium
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing amlodipine besylate and atorvastatin calcium
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | CADUET | amlodipine besylate and atorvastatin calcium | 0069-2150 | CALCIUM CARBONATE | |
| Pfizer Laboratories Div Pfizer Inc | CADUET | amlodipine besylate and atorvastatin calcium | 0069-2150 | CELLULOSE, MICROCRYSTALLINE | |
| Pfizer Laboratories Div Pfizer Inc | CADUET | amlodipine besylate and atorvastatin calcium | 0069-2150 | CROSCARMELLOSE SODIUM | |
| Pfizer Laboratories Div Pfizer Inc | CADUET | amlodipine besylate and atorvastatin calcium | 0069-2150 | HYDROXYPROPYL CELLULOSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing amlodipine besylate and atorvastatin calcium
Detailed excipient profiles for amlodipine besylate and atorvastatin calcium
Excipient focus: CALCIUM CARBONATE
amlodipine besylate and atorvastatin calcium drug variants containing CALCIUM CARBONATE
amlodipine besylate and atorvastatin calcium drug variants not containing CALCIUM CARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and atorvastatin calcium drug variants containing CELLULOSE, MICROCRYSTALLINE
amlodipine besylate and atorvastatin calcium drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
amlodipine besylate and atorvastatin calcium drug variants containing CROSCARMELLOSE SODIUM
amlodipine besylate and atorvastatin calcium drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
amlodipine besylate and atorvastatin calcium drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing CROSPOVIDONE
Excipient focus: FD&C BLUE NO. 2
amlodipine besylate and atorvastatin calcium drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | amlodipine besylate and atorvastatin calcium | 54868-6335 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing FD&C BLUE NO. 2
Excipient focus: HYDROGENATED SOYBEAN LECITHIN
amlodipine besylate and atorvastatin calcium drug variants containing HYDROGENATED SOYBEAN LECITHIN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing HYDROGENATED SOYBEAN LECITHIN
Excipient focus: HYDROXYPROPYL CELLULOSE
amlodipine besylate and atorvastatin calcium drug variants containing HYDROXYPROPYL CELLULOSE
amlodipine besylate and atorvastatin calcium drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
amlodipine besylate and atorvastatin calcium drug variants containing MAGNESIUM STEARATE
amlodipine besylate and atorvastatin calcium drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3000
amlodipine besylate and atorvastatin calcium drug variants containing POLYETHYLENE GLYCOL 3000
amlodipine besylate and atorvastatin calcium drug variants not containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
amlodipine besylate and atorvastatin calcium drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYSORBATE 80
amlodipine besylate and atorvastatin calcium drug variants containing POLYSORBATE 80
amlodipine besylate and atorvastatin calcium drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
amlodipine besylate and atorvastatin calcium drug variants containing POLYVINYL ALCOHOL
amlodipine besylate and atorvastatin calcium drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
amlodipine besylate and atorvastatin calcium drug variants containing SILICON DIOXIDE
amlodipine besylate and atorvastatin calcium drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
amlodipine besylate and atorvastatin calcium drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing SODIUM BICARBONATE
Excipient focus: SODIUM LAURYL SULFATE
amlodipine besylate and atorvastatin calcium drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: STARCH, CORN
amlodipine besylate and atorvastatin calcium drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
amlodipine besylate and atorvastatin calcium drug variants not containing STARCH, CORN
Excipient focus: TALC
amlodipine besylate and atorvastatin calcium drug variants containing TALC
amlodipine besylate and atorvastatin calcium drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
amlodipine besylate and atorvastatin calcium drug variants containing TITANIUM DIOXIDE
amlodipine besylate and atorvastatin calcium drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
amlodipine besylate and atorvastatin calcium drug variants containing WATER
amlodipine besylate and atorvastatin calcium drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | amlodipine besylate and atorvastatin calcium | 43598-323 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
